Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET)

Contemp Clin Trials. 2019 Jan:76:120-131. doi: 10.1016/j.cct.2018.11.010. Epub 2018 Nov 22.

Abstract

Adjuvant endocrine therapy (AET) is used to prevent recurrence and reduce mortality for women with hormone receptor positive breast cancer. Poor adherence to AET is a significant problem and contributes to increased medical costs and mortality. A variety of problematic symptoms associated with AET are related to non-adherence and early discontinuation of treatment. The goal of this study is to test a novel, telephone-based coping skills training that teaches patients adherence skills and techniques for coping with problematic symptoms (CST-AET). Adherence to AET will be assessed in real-time for 18 months using wireless smart pill bottles. Symptom interference (i.e., pain, vasomotor symptoms, sleep problems, vaginal dryness) and cost-effectiveness of the intervention protocol will be examined as secondary outcomes. Participants (N = 400) will be recruited from a tertiary care medical center or community clinics in medically underserved or rural areas. Participants will be randomized to receive CST-AET or a general health education intervention (comparison condition). CST-AET includes ten nurse-delivered calls delivered over 6 months. CST-AET provides systematic training in coping skills for managing symptoms that interfere with adherence. Interactive voice messaging provides reinforcement for skills use and adherence that is tailored based on real-time adherence data from the wireless smart pill bottles. Given the high rates of non-adherence and recent recommendations that women remain on AET for 10 years, we describe a timely trial. If effective, the CST-AET protocol may not only reduce the burden of AET use but also lead to cost-effective changes in clinical care and improve breast cancer outcomes. Trials registration: ClinicalTrials.gov, NCT02707471, registered 3/3/2016.

Keywords: Adherence; Adjuvant endocrine therapy; Breast cancer; RCT; Self-management.

Publication types

  • Clinical Trial Protocol
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adaptation, Psychological*
  • Antineoplastic Agents, Hormonal* / adverse effects
  • Antineoplastic Agents, Hormonal* / therapeutic use
  • Aromatase Inhibitors* / adverse effects
  • Aromatase Inhibitors* / therapeutic use
  • Arthralgia / chemically induced
  • Breast Neoplasms* / drug therapy
  • Chemotherapy, Adjuvant
  • Fatigue / chemically induced
  • Female
  • Hot Flashes / chemically induced
  • Humans
  • Medication Adherence* / psychology
  • Pain / chemically induced
  • Randomized Controlled Trials as Topic
  • Self-Management* / education
  • Self-Management* / psychology
  • Sleep Wake Disorders / chemically induced
  • Sweating
  • Tamoxifen / adverse effects
  • Tamoxifen / therapeutic use
  • Telemedicine
  • Telephone*
  • Vaginal Diseases / chemically induced

Substances

  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Tamoxifen

Associated data

  • ClinicalTrials.gov/NCT02707471